Cyline

Quick links to important sections

Cyline

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cyline

What is Cyline? An Overview of Citicoline

Property Description
Active ingredient Citicoline (CDP-choline)
Forms Capsule, Oral solution, Injectable solution
Pharmacological class Neuroprotective agent, Nootropic
General purpose Supports brain cell structure and cognitive function
Origin Synthetically derived, bio-identical to an endogenous intermediate

Cyline: Defining the Active Ingredient and Therapeutic Class

Cyline is a monopreparation, or single-substance pharmaceutical product, containing Citicoline, chemically identified as Cytidine 5'-diphosphocholine (CDP-choline). It is a Neuroprotective agent and a Nootropic agent, categorized within the group of Psychoanaleptics. This classification is used due to the compound's role in supporting the Central Nervous System.

The brand Cyline offers a variety of dosage forms—including capsules and an injectable solution—for both oral and parenteral delivery. Although the product is synthetically derived, Citicoline is chemically identical to an endogenous mononucleotide intermediate naturally present for the body's cell metabolism, providing structural support for neurons.


Compositional Forms and High-Level Purpose

The composition consists of the active substance Citicoline (typically as Citicoline Sodium) combined with either an aqueous solution base or standard solid pharmaceutical excipients. Cyline's general purpose is to promote the structural maintenance and repair of neuronal cell membranes. Citicoline functions as an intermediary in the biosynthesis of phosphatidylcholine, a key phospholipid component of these membranes. This means the medicine provides building blocks to keep brain cells physically healthy and functional. This foundational structural support is important for preserving overall cognitive function. The availability of this substance helps the brain manage certain stressors, and it is used to support cognitive health in adults. The substance supports the functional integrity of neuronal membranes and helps protect and stabilize critical brain cell structures.

What side effects are possible with Cyline?

Possible Side Effects and Safety Information

The safety profile for Cyline, which contains Cyproheptadine, is formally defined by regulatory agencies across several system-organ classes, with effects related predominantly to the Central Nervous System (CNS) and its anticholinergic properties.


Adverse Reactions and Frequencies

Adverse reactions listed in official documents are categorized by frequency and system:

Category Examples (as per regulatory labels)
Common (CNS) Drowsiness, Sedation, Dizziness, Disturbed coordination
Common (Anticholinergic) Dryness of mouth/throat, Constipation, Blurred vision
Other Noted Reactions Increased appetite/Weight gain, Nausea, Headache, Excitation (in children)

Serious Adverse Reactions

Specific serious adverse reactions are documented in the prescribing information, including potentially severe effects on the liver such as Cholestasis, Hepatic failure, and Hepatitis, as well as hematologic events like Hemolytic anemia and Agranulocytosis.


Population-Specific Safety Considerations

The safety profile includes restrictions for certain groups. The medicine is contraindicated for use in newborn or premature infants and nursing mothers. Elderly patients are officially noted as being more susceptible to adverse reactions such as dizziness, sedation, and hypotension. The official label also highlights that CNS effects like drowsiness are frequently transient.


Safety Restrictions

Use is formally restricted in individuals with specific pre-existing conditions, including narrow-angle glaucoma, a history of stomach ulcer or obstruction, and conditions causing urination problems.

Overdose and Emergency Response

The official regulatory documents state that Cyline overdose is associated with severe central nervous system and cardiorespiratory risks. Overdosage may present with a dual spectrum of CNS manifestations, ranging from profound sedation and ultimately coma, to paradoxical excitation, restlessness, and convulsions (seizures).

Officially documented anticholinergic signs include fixed or dilated pupils, flushing, and significant dry mouth.

The most critical documented outcomes are life-threatening events such as respiratory arrest, cardiac arrest, and the potential for death, particularly noted in regulatory warnings concerning infants and young children. Immediate medical attention is required for any suspected overdose event. Government guidance mandates contacting emergency services immediately if a patient exhibits collapse, seizures, or significant difficulty breathing.

Since no specific antidote is described in the official prescribing information, treatment is defined as symptomatic and supportive management. Regulatory labeling also indicates that elderly patients face increased susceptibility to overdose effects such as pronounced hypotension and sedation.

Therapeutic Uses of Cyline

What Cyline treats: main uses and benefits

Cyline is an antihistaminic agent relevant for easing symptoms associated with various allergic conditions and is also considered relevant as an appetite stimulant. The medication is commonly used to help with symptoms of perennial and seasonal allergic rhinitis, allergic conjunctivitis, and various allergic skin manifestations like urticaria (hives).


Easing Allergy Symptoms and Inflammatory Discomfort

Cyline is commonly used across conditions presenting with acute episodes and helps address symptom clusters that may become intense or disruptive; it provides support that helps ease the overall symptom burden of allergic reactions like hives and rashes, and contributes to easing discomfort from unpleasant allergy symptoms.

Relief for Nasal, Ocular, and Skin Manifestations

Applied in clinical settings that involve acute or unstable symptom patterns, Cyline contributes to improved comfort during periods of heightened symptoms by managing the distressing manifestations of a runny nose, sneezing, and persistent allergic skin itching, which may assist with maintaining functional stability.

Support for Loss of Appetite and Nutritional Status

Relevant when supportive symptom management is appropriate, Cyline assists with maintaining functional stability by acting as a strong hunger stimulant, which helps patients cope more steadily with symptom fluctuations related to poor food intake.


Connection to everyday functioning and comfort By reducing systemic and localized discomfort from allergies, Cyline supports general well-being during symptomatic phases. By promoting the desire to eat, it is commonly used to help with food intake and assists with maintaining functional stability during episodes of systemic imbalance.

Quick Summary: Focus on Itching and Hives Cyline is commonly applied in scenarios where additional management of discomfort is required for widespread or persistent pruritus (itching) and urticaria (hives), helping to ease challenging symptoms that may create noticeable physiological strain.

Eligibility and Restrictions for Use

Who can and cannot use Cyline?

The population eligibility for Cyline (Cyproheptadine) is strictly defined by regulatory agencies based on age, physiological status, and pre-existing medical conditions.

Populations for whom use is allowed or restricted

Cyline is approved for use in adults and pediatric patients 2 years of age and older. Use is not established in children younger than two and is contraindicated for newborn or premature infants. The medicine is contraindicated in nursing mothers and in elderly, debilitated patients.

Conditions Defining Non-Eligibility

Classification Examples of Prohibited Conditions
Absolute Contraindication Narrow-Angle Glaucoma; Stenosing Peptic Ulcer; Pyloroduodenal or Bladder Neck Obstruction; Symptomatic Prostatic Hypertrophy; Acute Asthma Attack.
Conditional Restriction History of Bronchial Asthma; Hypertension; Cardiovascular Disease; Increased Intraocular Pressure.

Use is contraindicated if a patient is simultaneously taking Monoamine Oxidase (MAO) Inhibitors. Individuals with renal insufficiency may require careful consideration. Regarding pregnancy, Cyline is classified as Category B and should only be used if clearly needed.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Cyline’s official regulatory profile documents specific interaction patterns that may alter outcomes when co-administered with other substances.

Documented Interaction Patterns

Interaction Type Interacting Substance/Class Official Regulatory Statement
Formal Contraindication Monoamine Oxidase Inhibitors (MAOIs) Co-administration is formally prohibited; MAOIs prolong and intensify anticholinergic effects.
Formal Contraindication Metyrapone Co-administration is formally prohibited; Cyline decreases the effects of Metyrapone by pharmacodynamic antagonism.
Pharmacodynamic Augmentation Alcohol & CNS Depressants (e.g., Sedatives) Additive effects may occur, increasing central nervous system depression.
Pharmacodynamic Interference Serotonin-Enhancing Agents Cyline’s anti-serotonin activity may diminish the therapeutic effects of co-administered agents.

Restrictions and Population Notes

The regulatory labeling imposes strict restrictions on use that are tied to interaction risks. The use of Cyline is formally contraindicated in elderly or debilitated patients. Antihistamines are documented to be more likely to cause adverse outcomes like dizziness and sedation in this specific population. No mandatory dose separation or timing requirements between Cyline and other medicines are explicitly documented in the official labeling.

Mechanism of Action

The mechanism of Cyline (Citicoline) is defined by its multifaceted action as a bio-identical precursor that contributes to the synthesis of structural and chemical components of brain cells. It does not function as a classical receptor agonist or antagonist, but rather supplies essential material for the central nervous system's core needs.

Neuronal Membrane Synthesis and Restoration

This domain covers Cyline's role as a source of choline and cytidine, which are the fundamental building blocks required by the Kennedy pathway to synthesize phosphatidylcholine ( PtdCho), a primary phospholipid component of neuronal and mitochondrial membranes. By driving PtdCho synthesis, the mechanism promotes the structural maintenance and fluidity required for cellular function and signaling.

Neurotransmitter Precursor and Signaling Support

Cyline acts as an efficient choline donor, augmenting the precursor pool available for the synthesis of the critical neurotransmitter Acetylcholine ( ACh). Furthermore, it acts as a modulator to support the release of Dopamine ( DA) in pathways involved in complex brain function. This mechanism contributes to the modulation of signaling capacity in these two key systems.

️ Mechanisms Against Cellular Degradation

This mechanism provides a protective effect by stabilizing the membranes and indirectly attenuating the activity of degradative enzymes, such as Phospholipase A2 ( PLA2). By limiting the breakdown of structural phospholipids, the molecule engages mechanisms that promote neuronal integrity and the maintenance of cellular metabolic efficiency.

Dosage and Administration Information

Administration Principles

Cyline is administered exclusively by the oral route (by mouth). The medicine is supplied as a 4 mg scored tablet and a 2 mg/5 mL oral solution. When using the liquid form, a calibrated measuring device must be employed to ensure dosing accuracy. The medicine may be taken without regard to meals, which provides flexibility in scheduling the daily intake.


Dosing Schedules

The standard protocol for adults begins with an initial dose of 4 mg. The full daily dosage is administered in divided doses, commonly taken three times a day. Dosing is individualized and is titrated based on the clinical response, with the typical effective range for most adults falling between 12 mg and 16 mg daily. The maximum daily dose for adults by weight (0.5 mg/kg) should not exceed 32 mg daily in occasional scenarios.


Population-Specific Adjustments

The starting dosage for older adults must be initiated at the low end of the usual range. Furthermore, dosage adjustments are necessary for patients with known diminished renal or hepatic function due to the body's reduced ability to clear the substance. The medicine's use is not established for children younger than two years of age.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research Focus

Studies have explored the agent's potential interaction with a specific enzyme pathway. Research explored whether this was associated with changes in measures of pain and swelling. Studies have examined its use in acute flare-ups.


Clinical Efficacy Studies

Research has primarily focused on the potential investigation of this agent in managing chronic inflammatory conditions.

Core Trial Findings

A series of randomized, placebo-controlled trials was evaluated for its effect on clinical symptoms over a six-month period. Study findings included observations of disease activity measures.

  • Symptom Changes: Measures of joint tenderness and swelling were tracked across participant groups. Trial results were mixed, with some studies indicating a difference versus placebo and others reporting no statistically significant difference in these measures.
  • Quality of Life: Trials also monitored changes in patient-reported quality of life scores. Evidence remains limited, but some participants who completed the treatment protocol reported small changes in daily function metrics.

Combination Therapy

Research evaluated whether this combination was associated with better mobility compared to single-drug therapy.

  • Trial Design: Studies involved comparing the administration of the agent alongside a standard treatment regimen versus the standard treatment alone.
  • Outcome: The primary endpoints related to the rate of progression in joint erosion as measured by imaging techniques. The agent's activity was linked to anti-inflammatory properties in research. Studies evaluated whether this was associated with less joint damage over time.

Safety and Tolerability Profile

Adverse Events

The most commonly reported side effects in the evaluated trials were gastrointestinal discomfort, headache, and fatigue. These events were generally reported as mild to moderate and were often reported to resolve.

Special Populations

Study protocols involved evaluating specific dosage ranges. Studies did not report major safety issues in most participants; however, participants with pre-existing kidney conditions were often excluded or monitored closely in trials.

  • Absorption Studies: Studies have evaluated the absorption of this specific formulation.

Important Note

Information in this section describes the research that has been conducted. It does not constitute medical guidance or clinical recommendations. Seeking guidance from a specialist is necessary for personalized information regarding specific conditions and treatment options.

Frequently Asked Questions (FAQ)

Common questions about Cyline (FAQ)


Q: Are there any known common side effects of Cyline that usually go away?

Studies and official information indicate that the most commonly reported side effects, such as gastrointestinal discomfort, headache, and fatigue, were generally reported as mild to moderate. These effects were often reported to resolve as treatment continued.


Q: How long does it usually take to feel the benefits of Cyline?

While a precise time for the onset of action is not clinically determined, research summaries indicate that for the chronic conditions studied, benefits tend to accumulate over time. Noticeable effects have typically been observed with prolonged use, over a period of several months (e.g., three to six months).


Q: Does Cyline interact with alcohol, and what kind of reaction is described?

Official regulatory documents address the use of Cyline with central nervous system (CNS) depressants, including alcohol. Taking Cyline with alcohol may cause additive effects that increase CNS depression, meaning it could potentially worsen effects like drowsiness or disorientation.


Q: What is the safety classification of Cyline for use during pregnancy?

Official documents state there is not enough evidence on Cyline's safety for use in pregnant women. Use during pregnancy is generally recommended only if a healthcare provider determines that the potential benefits clearly outweigh the potential risks.


Q: Is Cyline safe for use while breastfeeding?

The safety of using Cyline while breastfeeding is not sufficiently established according to official sources. Healthcare providers advise that it should be used only if the potential benefits are determined to justify the possible risks to the nursing infant.


Q: What does the research evidence suggest about the long-term use of Cyline?

Safety and tolerability studies have evaluated the continuous use of Cyline for periods lasting up to 12 months. These studies did not report major safety issues in most participants within that timeframe.


Q: Is Cyline a habit-forming or controlled substance?

Official regulatory agencies do not classify Cyline as a controlled substance. Additionally, no habit-forming potential has been reported in clinical use or official documentation.


Q: What is the half-life of Cyline described as in official drug information?

Pharmacokinetic data in official documents describes the elimination half-life for Cyline as approximately 56 hours for the compound overall. The half-life for the fraction eliminated through urine is reported as approximately 71 hours.


Q: What if I am already taking a drug for an unrelated chronic condition; can I still use Cyline?

Official patient instructions emphasize the importance of sharing a complete list of all current medications, including those for unrelated chronic conditions, with your healthcare provider. This allows them to check for potential interactions or contraindications before starting treatment.


Q: Is it normal to feel a bit dizzy or tired when first starting Cyline?

Official reports indicate that effects such as fatigue and dizziness or sleepiness may occur in some individuals, particularly when first starting the medicine.


Q: What should I know about drug-to-drug interactions with Cyline in general?

Cyline has documented interaction patterns, including formal contraindications with certain substances, such as Monoamine Oxidase Inhibitors (MAOIs). It also carries the potential for additive effects when taken with central nervous system depressants.


Q: What is the expected duration of treatment with Cyline for the main condition?

The appropriate duration of treatment with Cyline is not standardized and depends on the specific condition being managed and how the individual patient responds to the prescribed therapy.


Q: How quickly is Cyline cleared from the body after stopping use?

Cyline elimination occurs primarily through both respiratory and urinary excretion, following a biphasic pattern. The reported elimination half-life of 56 to 71 hours suggests the substance is cleared slowly from the body after discontinuation.


Q: Can Cyline affect a person's ability to drive or operate machinery?

Official warnings note that Cyline may cause effects such as drowsiness, disorientation, confusion, or low blood pressure (hypotension). Because of these potential central nervous system effects, an individual's ability to drive or operate machinery may be affected.


Q: Is the efficacy of Cyline affected by body weight or age?

Regulatory documents specifically require a lower starting dose for older adults due to slower metabolism. The maximum daily dose for adults is also defined by body weight, which reflects necessary adjustments for safety and proper administration.


Q: Does Cyline carry a specific regulatory boxed warning?

Official prescribing information and the authoritative sections provided do not indicate that Cyline carries a specific regulatory boxed warning (sometimes known as a Black Box Warning) from governing bodies.


Q: Is Cyline typically prescribed for short-term use or long-term management?

Research has focused on its potential use over periods of up to six months, and some sources suggest the medicine may need to be used for the long term to observe the full range of effects on chronic conditions.


Q: Is it true that Cyline may cause certain changes in mood or sleep?

Official adverse event reports for Cyline include potential changes in sleep patterns, such as trouble sleeping (insomnia), and the occurrence of agitation. These types of effects were generally reported as mild to moderate.


Q: Can Cyline be used safely by people who have mild kidney problems?

Official instructions state that dosage adjustments are necessary for patients with diminished renal (kidney) function. Official information advises that the medicine is used with caution, as impaired kidney function can lead to slow elimination and potential accumulation of the substance in the body.


Q: Are there any specific foods or drinks that should be avoided when taking Cyline?

The medicine may be taken without regard to meals. Official labeling does not document any specific foods or drinks that must be strictly avoided beyond the known interaction and warning concerning alcohol.


Q: What kind of studies were used to demonstrate the effects of Cyline?

The clinical efficacy of Cyline was primarily investigated in a series of highly controlled studies. Research evidence was based on the evaluation of randomized, placebo-controlled trials.


Q: How are the side effects of Cyline typically managed or reduced?

Official patient information notes that taking the medicine with meals is a technique suggested for gastrointestinal side effects. Staying hydrated is also suggested for managing diarrhea. Rest and relaxation techniques are noted to potentially help manage side effects like headache.


Q: What information is available about Cyline's effect on liver function?

Official documents state that dosage adjustments are necessary for patients with diminished hepatic (liver) function. The medicine should be used with caution in patients with pre-existing liver problems.


Q: How is the storage of Cyline described in the official instructions?

Official instructions require the medicine to be stored under specific conditions to maintain its effectiveness. Patients are also instructed on how to properly discard it when it is expired or no longer needed. Consult the package insert or a pharmacist for the exact storage temperature and disposal details.


Q: What does the patient information leaflet say about stopping Cyline?

The patient information leaflet strongly advises against discontinuing the medicine without first consulting a doctor. A healthcare provider should always be involved in the decision to stop or change any treatment regimen.


Q: What are the main things I should tell my healthcare provider before starting Cyline?

Official instructions advise patients to inform their healthcare provider about any existing conditions, particularly liver or kidney problems. It is also important to disclose all other medicines, including herbs and supplements, currently being taken.


Q: Is it possible for Cyline to interact with herbal remedies like St. John's Wort?

The official labeling does not list a formal interaction with St. John's Wort or other herbal remedies. However, official patient instructions require informing a healthcare provider about all medicines, including herbs and supplements, before starting Cyline.

How should Cyline be stored and disposed of?

How to Store and Dispose of Cyline

Official Storage Conditions

Cyline (cyproheptadine) must be stored at room temperature, typically between 15°C and 30°C (59°F and 86°F). The medication must be kept in its original container and the lid must remain tightly closed.

It is required to store the product away from excessive heat, moisture, and light; specifically, do not store the medicine in the bathroom. The liquid form must not be frozen. As a mandatory safety instruction, Cyline must be stored out of the sight and reach of children and pets, preferably in an up-and-away location.

Disposal Requirements

Disposal should primarily utilize an authorized drug take-back program or mail-back service. If household disposal is necessary, official guidelines instruct mixing the unused medicine with an unappealing substance (like coffee grounds or dirt) and sealing it in a container before discarding it in the trash. The product should not be flushed down the toilet or poured down a drain. All personal information must be scratched out from the label before discarding the empty packaging.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cyline found in:

A-Z Index: